Editorial: weighing the global risk of cancer with thiopurines in inflammatory bowel disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|47|5|689-690

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.47, Iss.5, 2018-03, pp. : 689-690

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: weighing the global risk of cancer with thiopurines in inflammatory bowel disease—Authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 5, 2018-03 ,pp. : 690-691

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic review with meta‐analysis: thiopurines decrease the risk of colorectal neoplasia in patients with inflammatory bowel disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 318-331

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of Azathioprine and the Risk of Cancer in Inflammatory Bowel Disease

By Pasternak Björn   Svanström Henrik   Schmiegelow Kjeld   Jess Tine   Hviid Anders  

American Journal of Epidemiology, Vol. 177, Iss. 11, 2013-06 ,pp. : 1296-1305

Oxford University Press

Access to resources Recommend Favorite

Impact of early thiopurines on surgery in 2770 children and young people diagnosed with inflammatory bowel disease: a national population‐based study

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 8, 2015-10 ,pp. : 990-999

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of early thiopurines on surgery in 2770 children and young people diagnosed with inflammatory bowel disease: a national population‐based study

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 269-2813, Iss. 8, 2015-10 ,pp. : 990-999

John Wiley & Sons Inc

Access to resources Recommend Favorite